CD8A and neoplasm: The results revealed enhanced oligoclonal expansion of tumor-reactive CD8+ T cells of the NDV-GP group in relation to those of the PBS or NDV-WT groups (Fig. 6b), suggesting potential T cell epitope spreading of tumor-reactive CD8+ T cells in the presence of OV-BYTE therapy.